Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
57,664,502
-
Share change
-
+190,385
-
Total reported value
-
$7,350,056,970
-
Put/Call ratio
-
213%
-
Price per share
-
$127.40
-
Number of holders
-
422
-
Value change
-
+$21,422,030
-
Number of buys
-
174
-
Number of sells
-
221
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2021
As of 31 Dec 2021,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
422 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,664,502 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, Polaris Capital Management, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
423
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.